Company Filing History:
Years Active: 2019-2023
Title: Innovations by Inventor Ping Yu
Introduction
Ping Yu is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of human immunodeficiency virus (HIV) treatment. With a total of 2 patents, his work focuses on developing compounds that can effectively bind to HIV RNA.
Latest Patents
Ping Yu's latest patents include innovative compounds that bind to the human immunodeficiency virus rev response element (RRE). These compounds, which may consist of peptides or peptide mimetics, are designed to inhibit the binding of Rev to the RRE RNA. In various embodiments, the compounds feature two moieties, each targeting one of the Rev binding sites in the RRE. Some of these moieties include peptides or small molecules, with certain peptides containing an arginine-rich motif. Additionally, the RRE binding compounds can be linked to a detectable label or cargo moiety. The patents also outline methods for treating or inhibiting HIV by administering one or more of these RRE binding compounds to a subject.
Career Highlights
Ping Yu is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute to groundbreaking research in the fight against HIV.
Collaborations
Ping Yu collaborates with various professionals in his field, including his coworker Yun-Xing Wang. Their combined expertise enhances the research efforts aimed at developing effective treatments for HIV.
Conclusion
Ping Yu's innovative work in developing compounds that target HIV RNA showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against HIV, and his patents reflect the potential for significant advancements in treatment options.